WHO holds urgent talks on Ebola treatments
Al-jazeera.com :
World health experts are meeting in Geneva, Switzerland for the second day of urgent talks on fast-tracking experimental Ebola drugs, as doctors in the worst-hit African countries pleaded to be given the serums.
With no fully tested treatments for Ebola, the World Health Organisation (WHO) has endorsed potential cures like ZMapp to be rushed out.
“Everybody keeps asking why isn’t this medication made available to our people out there?” Samuel Kargbo, from Sierra Leone’s ministry of health, told the AFP news agency. ZMapp has been given to about 10 health workers who contracted the virus, including Americans and Europeans, three of whom recovered.
Infographic: Just how deadly is Ebola?
Its stocks have been exhausted, but the WHO said a few hundred doses could potentially be ready by the end of the year.
“Our doctors who have been treating patients are also dying, and it’s not made available,” Kargbo said.
The two-day closed-door meeting of about 200 health experts in Geneva is discussing eight potential therapies, as well as two experimental vaccines.
World health experts are meeting in Geneva, Switzerland for the second day of urgent talks on fast-tracking experimental Ebola drugs, as doctors in the worst-hit African countries pleaded to be given the serums.
With no fully tested treatments for Ebola, the World Health Organisation (WHO) has endorsed potential cures like ZMapp to be rushed out.
“Everybody keeps asking why isn’t this medication made available to our people out there?” Samuel Kargbo, from Sierra Leone’s ministry of health, told the AFP news agency. ZMapp has been given to about 10 health workers who contracted the virus, including Americans and Europeans, three of whom recovered.
Infographic: Just how deadly is Ebola?
Its stocks have been exhausted, but the WHO said a few hundred doses could potentially be ready by the end of the year.
“Our doctors who have been treating patients are also dying, and it’s not made available,” Kargbo said.
The two-day closed-door meeting of about 200 health experts in Geneva is discussing eight potential therapies, as well as two experimental vaccines.